101 related articles for article (PubMed ID: 8674581)
41. Separation of dermatan sulfate from heparan sulfate in mucopolysaccharidosis urine by chromatography on Sephadex G-75.
Herd JK; Forrest T; Tschida J
Clin Chim Acta; 1976 Apr; 68(1):1-9. PubMed ID: 131009
[TBL] [Abstract][Full Text] [Related]
42. Measuring urinary glycosaminoglycans in the presence of protein: an improved screening procedure for mucopolysaccharidoses based on dimethylmethylene blue.
de Jong JG; Wevers RA; Liebrand-van Sambeek R
Clin Chem; 1992 Jun; 38(6):803-7. PubMed ID: 1597005
[TBL] [Abstract][Full Text] [Related]
43. Urinary glycosaminoglycans in patients with systemic lupus erythematosus.
De Muro P; Faedda R; Formato M; Re F; Satta A; Cherchi GM; Carcassi A
Clin Exp Rheumatol; 2001; 19(2):125-30. PubMed ID: 11326473
[TBL] [Abstract][Full Text] [Related]
44. Increased urinary excretion of acid mucopolysaccharides and glycopeptides in hypothyroidism following thyroid hormone therapy.
Tokoro T; Eto Y
Eur J Pediatr; 1985 May; 144(1):84-6. PubMed ID: 3160592
[TBL] [Abstract][Full Text] [Related]
45. A new quantitative assay for glycosaminoglycans.
Thuy LP; Nyhan WL
Clin Chim Acta; 1992 Nov; 212(1-2):17-26. PubMed ID: 1486678
[TBL] [Abstract][Full Text] [Related]
46. Effect of urinary stone disease and extracorporeal shockwave lithotripsy on excretion of glycosaminoglycans.
Erkurt B; Ilker Y; Budak Y; Ozveren B; Türkeri L; Akdas A
J Endourol; 1999 Oct; 13(8):553-7. PubMed ID: 10597124
[TBL] [Abstract][Full Text] [Related]
47. Electrophoretic separation and characterization of urinary glycosaminoglycans and their roles in urolithiasis.
Gohel MD; Shum DK; Tam PC
Carbohydr Res; 2007 Jan; 342(1):79-86. PubMed ID: 17145044
[TBL] [Abstract][Full Text] [Related]
48. Urinary glycosaminoglycan excretion as a biochemical marker in patients with bladder carcinoma.
Hennessey PT; Hurst RE; Hemstreet GP; Cutter G
Cancer Res; 1981 Oct; 41(10):3868-73. PubMed ID: 6793229
[TBL] [Abstract][Full Text] [Related]
49. Glycosaminoglycans of skin and urine in pseudoxanthoma elasticum: evidence for chondroitin 6-sulfate alteration.
Longas MO; Wisch P; Lebwohl MG; Fleischmajer R
Clin Chim Acta; 1986 Mar; 155(3):227-36. PubMed ID: 3085984
[TBL] [Abstract][Full Text] [Related]
50. Subunit structure of isomeric chondroitin sulfates from normal human urine.
Taniguchi N; Okamoto T; Okuda N
Biochem Med; 1976 Apr; 15(2):169-77. PubMed ID: 962901
[No Abstract] [Full Text] [Related]
51. Sulphated glycosaminoglycans of exponentially growing and non-proliferating BHK-21/C13 cells [proceedings].
Watson HH; Edward M; Williamson FB; Long WF
Biochem Soc Trans; 1980 Feb; 8(1):134-6. PubMed ID: 6445296
[No Abstract] [Full Text] [Related]
52. Rapid and sensitive determination of enzymatic degradation products of isomeric chondroitin sulfates by high-performance liquid chromatography.
Lee GJ; Evans JE; Tieckelmann H
J Chromatogr; 1978 Nov; 146(3):439-48. PubMed ID: 102653
[TBL] [Abstract][Full Text] [Related]
53. The urinary excretion of heparan sulfate by juvenile- and adult-onset diabetic patients.
Bonavita N; Reed P; Donnelly PV; Hill LL; DiFerrante N
Connect Tissue Res; 1984; 13(1):83-7. PubMed ID: 6242398
[TBL] [Abstract][Full Text] [Related]
54. A spectrophotometric microassay for sulfated glycosaminoglycans using a laser densitometer.
Klompmakers AA; Hendriks T
Anal Biochem; 1986 Feb; 153(1):80-4. PubMed ID: 3083716
[TBL] [Abstract][Full Text] [Related]
55. The application of high-performance liquid chromatography in enzymatic assays of chondroitin sulfate isomers in normal human urine.
Lee GJ; Tieckelmann H
J Chromatogr; 1981 Jan; 222(1):23-31. PubMed ID: 6783674
[TBL] [Abstract][Full Text] [Related]
56. Urinary chondroitin sulfates, heparan sulfate and total sulfated glycosaminoglycans in interstitial cystitis.
Erickson DR; Ordille S; Martin A; Bhavanandan VP
J Urol; 1997 Jan; 157(1):61-4. PubMed ID: 8976216
[TBL] [Abstract][Full Text] [Related]
57. A low-sulfated chondroitin sulfate in rat blood: an acidic glycosaminoglycan with a high metabolic rate.
Hata RI; Nagai Y
Biochim Biophys Acta; 1978 Oct; 543(2):149-55. PubMed ID: 728457
[TBL] [Abstract][Full Text] [Related]
58. Differences in the nonreducing ends of heparan sulfates excreted by patients with mucopolysaccharidoses revealed by bacterial heparitinases: a new tool for structural studies and differential diagnosis of Sanfilippo's and Hunter's syndromes.
Toma L; Dietrich CP; Nader HB
Lab Invest; 1996 Dec; 75(6):771-81. PubMed ID: 8973472
[TBL] [Abstract][Full Text] [Related]
59. Prospective Evaluation of Chondroitin Sulfate, Heparan Sulfate and Hyaluronic Acid in Prostate Cancer.
da Silva MNR; Mendes A; Martins JRM; Tobias-Machado M; Pinhal MADS
Int Braz J Urol; 2018; 44(6):1139-1146. PubMed ID: 30516927
[TBL] [Abstract][Full Text] [Related]
60. Analysis of glycosaminoglycans in human serum after oral administration of chondroitin sulfate.
Baici A; Hörler D; Moser B; Hofer HO; Fehr K; Wagenhäuser FJ
Rheumatol Int; 1992; 12(3):81-8. PubMed ID: 1411092
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
